Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy
Titel:
Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy
Auteur:
Desai, Milind Y. Wolski, Kathy Owens, Anjali Naidu, Srihari S. Geske, Jeffrey B. Smedira, Nicholas G. Schaff, Hartzell Lampl, Kathy McErlean, Ellen Sewell, Christina Zhang, David Edelberg, Jay M. Sehnert, Amy J. Nissen, Steven E.